Complex karyotype, older age, and reduced first-line dose intensity determine poor survival in core binding factor acute myeloid leukemia patients with long-term follow-up.

导出 LinkOut

翻译打印收藏纠错

作者： Federico,Mosna ^[1] ; Cristina,Papayannidis ^[2] ; Giovanni,Martinelli ^[2] ; Eros,Di Bona ^[3] ; Angela,Bonalumi ^[4] ; Cristina,Tecchio ^[4] ; Anna,Candoni ^[5] ; Debora,Capelli ^[6] ; Andrea,Piccin ^[7] ; Fabio,Forghieri ^[8] ; Catia,Bigazzi ^[9] ; Giuseppe,Visani ^[10] ; Renato,Zambello ^[11] ; Lucia,Zanatta ^[12] ; Francesca,Volpato ^[1] ; Stefania,Paolini ^[2] ; Nicoletta,Testoni ^[2] ; Filippo,Gherlinzoni ^[1] ; Michele,Gottardi ^[1]

作者单位： Department of Hematology, General Hospital, Treviso, Italy. ^[1] Department of Hematology, Ist "LA Seragnoli," University of Bologna, Bologna, Italy. ^[2] Department of Hematology, General Hospital, Vicenza, Italy. ^[3] Department of Hematology, University of Verona, Verona, Italy. ^[4] Department of Hematology, University of Udine, Udine, Italy. ^[5] Department of Hematology, General Hospital, Ancona, Italy. ^[6] Department of Hematology, General Hospital, Bolzano, Italy. ^[7] Department of Hematology, University of Modena, Modena, Italy. ^[8] Department of Hematology, General Hospital, Ascoli-Piceno, Italy. ^[9] Department of Hematology, General Hospital, Pesaro, Italy. ^[10] Department of Hematology, University of Padova, Padova, Italy. ^[11] Department of Pathology, General Hospital, Treviso, Italy. ^[12]